Result:Good· Market: Up#Broad based#Margin expansion#Base effect
| Metric | Value (₹ Cr) | vs Q4 FY26 |
|---|---|---|
| Revenue | 9.26 | 9.5% |
| Total Income | 9.45 | 9.4% |
| Expenditure | 8.13 | 8.1% |
| PBT | 1.32 | 16.3% |
| Net Profit | 0.94 | 14.7% |
| OPM | 12.34% | 1.33pp |
| NPM | 9.96% | 0.62pp |
| EPS | 3.14 | 14.4% |
Revenue +84% YoY with OPM expanding from 7.2% to 12.3% drove 171% PAT growth, but the tiny ₹5 Cr prior-year base for this micro-cap chemical name caps it below very_good.
Informational and educational content only. Not investment advice.